Anacor Pharmaceuticals, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8d0411a3-d0ce-4274-9350-bd2eec59927a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-56.4M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010583 |
| FY 2014 | $-90.8M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-002293 |
| FY 2013 | $92.5M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-002522 |
| FY 2012 | $-53.2M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-002983 |
| FY 2011 | $-46.3M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-002766 |
| FY 2010 | $-9.5M | 2010-01-01 – 2010-12-31 | evidence 0001047469-12-002766 |
| FY 2009 | $-22.5M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-002766 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).